Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Chronic Kidney Diseases
In brief
This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.
Key facts
- Study ID
- NCT04500665
- Run by
- Brigham and Women's Hospital
- People needed
- 20
- Starts
- 2021-11-01
- Expected to finish
- 2026-11-11
- Last updated by the study team
- 2025-09-23
Who can join
Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.